Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine
暂无分享,去创建一个
Frank Verhaegen | Frank Hoebers | Andre Dekker | Philippe Lambin | Sean Walsh | Wouter van Elmpt | Geert Bosmans | Timo M Deist | Cary Oberije | Erik Roelofs | Catharina M L Zegers | Liesbeth Boersma | Ruben T H M Larue | Evert van Limbergen | Ruud Houben | Bart Reymen | Ben Vanneste | P. Lambin | R. Larue | R. Leijenaar | F. Hoebers | L. Boersma | S. Carvalho | S. Walsh | W. V. van Elmpt | E. D. de Jong | T. Deist | C. Oberije | A. Dekker | F. Verhaegen | A. Berlanga | E. Roelofs | K. Smits | G. Bosmans | M. Berbée | B. Reymen | J. Peerlings | A. Even | J. Zindler | B. Vanneste | D. Eekers | C. Zegers | M. Jacobs | E. V. Van Limbergen | L. Van De Voorde | Ralph T H Leijenaar | Qing Cheng | R. Houben | Sara Carvalho | Jaap Zindler | Maaike Berbee | Jurgen Peerlings | Kim Smits | Maria Jacobs | Aniek J G Even | Lien van de Voorde | Daniëlle Eekers | Evelyn E C de Jong | Adriana J Berlanga | Qing Cheng | W. van Elmpt
[1] C Bain,et al. Choosing between randomised and non-randomised studies: a systematic review. , 1998, Health technology assessment.
[2] Arek Kasprzyk,et al. The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] Latha P Palaniappan,et al. Problems with the collection and interpretation of Asian-American health data: omission, aggregation, and extrapolation. , 2012, Annals of epidemiology.
[4] P. Lambin,et al. Independent and functional validation of a multi-tumour-type proliferation signature , 2012, British Journal of Cancer.
[5] T. Francis. Evaluation of the 1954 poliomyelitis vaccine field trial; further studies of results determining the effectiveness of poliomyelitis vaccine (Salk) in preventing paralytic poliomyelitis. , 1955, Journal of the American Medical Association.
[6] Gunjan Sinha,et al. United Kingdom becomes the cancer clinical trials recruitment capital of the world. , 2007, Journal of the National Cancer Institute.
[7] P. Lambin,et al. The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] B. Raaymakers,et al. RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial , 2015, Trials.
[9] Glenn Fung,et al. A Simple but Highly Effective Approach to Evaluate the Prognostic Performance of Gene Expression Signatures , 2011, PloS one.
[10] P. O'Brien,et al. Obstacles to participation in randomised cancer clinical trials: A systematic review of the literature , 2012, Journal of medical imaging and radiation oncology.
[11] J. Firth. Should you tell patients about beneficial treatments that they cannot have? No , 2007, BMJ : British Medical Journal.
[12] P. Lambin,et al. Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation. , 2012, Lung cancer.
[13] G. Elwyn,et al. Shared decision making: really putting patients at the centre of healthcare , 2012, BMJ : British Medical Journal.
[14] Aleix Prat Aparicio. Comprehensive molecular portraits of human breast tumours , 2012 .
[15] Shipeng Yu,et al. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy. , 2009, International journal of radiation oncology, biology, physics.
[16] Patrick Granton,et al. Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.
[17] M J Campbell,et al. Choosing between randomised and non-randomised studies: a systematic review , 1998, BMJ.
[18] E. Yorke,et al. Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. , 2010, International journal of radiation oncology, biology, physics.
[19] Andre Dekker,et al. Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] S. van Dulmen,et al. Longer-term influence of breast cancer genetic counseling on cognitions and distress: smaller benefits for affected versus unaffected women. , 2011, Patient Education and Counseling.
[21] J. Deasy,et al. Radiation dose-volume effects in radiation-induced rectal injury. , 2010, International journal of radiation oncology, biology, physics.
[22] E. D. Geijsen,et al. Shared decision making: prostate cancer patients' appraisal of treatment alternatives and oncologists' eliciting and responding behavior, an explorative study. , 2011, Patient education and counseling.
[23] R. Thomson,et al. Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.
[24] P. Lambin,et al. Learning methods in radiation oncology ‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy’ q , 2013 .
[25] Shipeng Yu,et al. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] S. Walsh,et al. A TCP model for external beam treatment of intermediate-risk prostate cancer. , 2013, Medical physics.
[27] Armia George,et al. PROFFERED PAPERS: CLINICAL 2: LUNG CANCEROC-0063: Rapid learning in practice: A lung cancer survival decision support system in routine patient care data , 2014 .
[28] M. Baker,et al. Overhauling clinical trials , 2007, Nature Biotechnology.
[29] Frank Hoebers,et al. Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] Philippe Lambin,et al. PET imaging of hypoxia using [18F]HX4: a phase I trial , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[31] D. Berry. Bayesian clinical trials , 2006, Nature Reviews Drug Discovery.
[32] R. Prescott,et al. Barriers to participation in randomised controlled trials: a systematic review. , 1999, Journal of clinical epidemiology.
[33] M. Olschewski,et al. Comprehensive Cohort Study: An Alternative to Randomized Consent Design in a Breast Preservation Trial , 1985, Methods of Information in Medicine.
[34] F. Lagerwaard,et al. The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[35] Cyrus R Mehta,et al. Adaptive increase in sample size when interim results are promising: A practical guide with examples , 2011, Statistics in medicine.
[36] Vincenzo Valentini,et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Frank Verhaegen,et al. Results of a Multicentric In Silico Clinical Trial (ROCOCO): Comparing Radiotherapy with Photons and Protons for Non-small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[38] A. Carr,et al. Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. , 1998, Health technology assessment.
[39] P. Lambin,et al. Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] N. Obuchowski,et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.
[41] John B. Young,et al. Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design. , 2015, Age and ageing.
[42] Benjamin Movsas,et al. Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis. , 2007, International journal of radiation oncology, biology, physics.
[43] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[44] P. Lambin,et al. Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[45] G. Collins,et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC Medicine.
[46] P. Lambin,et al. Predicting outcomes in radiation oncology—multifactorial decision support systems , 2013, Nature Reviews Clinical Oncology.
[47] Chalapathy Neti,et al. Rapid-learning system for cancer care. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] M. Zelen. A new design for randomized clinical trials. , 1979, The New England journal of medicine.
[49] P. Lambin,et al. The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[50] P. Lambin,et al. No association between TGF-β1 polymorphisms and radiation-induced lung toxicity in a European cohort of lung cancer patients. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[51] Harlan M Krumholz,et al. Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.
[52] France Légaré,et al. Decision aids for people facing health treatment or screening decisions. , 2017, The Cochrane database of systematic reviews.
[53] P. Lambin,et al. Effectiveness of surgery and individualized high-dose hyperfractionated accelerated radiotherapy on survival in clinical stage I non-small cell lung cancer. A propensity score matched analysis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[54] H. Bastian,et al. Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up? , 2010, PLoS medicine.
[55] P. Lambin,et al. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325). , 2011, International journal of radiation oncology, biology, physics.
[56] Glenn Fung,et al. Impact of supervised gene signatures of early hypoxia on patient survival. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[57] M. Taphoorn,et al. Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[58] J. van Soest,et al. An umbrella protocol for standardized data collection (SDC) in rectal cancer: a prospective uniform naming and procedure convention to support personalized medicine. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[59] Satoshi Suzuki,et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. , 2014, The Lancet. Oncology.
[60] G. Collins,et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement , 2015, Annals of Internal Medicine.
[61] M. Parmar,et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).
[62] Jon Nicholl,et al. Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design , 2010, BMJ : British Medical Journal.
[63] C. Brewin,et al. Patient preferences and randomised clinical trials. , 1989, BMJ.
[64] P. Lambin,et al. Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.